| Period Ending | 31-Jan-2013 | 31-Jan-2012 | 31-Jan-2011 |
|---|
|
Total Revenue
|
462,501
|
496,387
|
521,055
| | Cost of Revenue | 296,030 | 322,672 | 333,664 | | |
Gross Profit
|
166,471
|
173,715
|
187,391
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 174,461 | 185,107 | 184,142 |
|
Non Recurring |
-
| 244 |
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(7,990)
|
(11,636)
|
3,249
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 147 | 275 | 156 |
|
Earnings Before Interest And Taxes | (7,843) | (11,361) | 3,405 |
|
Interest Expense | 1,173 | 1,334 | 1,014 |
|
Income Before Tax | (9,016) | (12,695) | 2,391 |
|
Income Tax Expense | 297 | 4,884 | 686 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (9,313) | (17,579) | 1,705 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(9,313)
|
(17,579)
|
1,705
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(9,313)
|
(17,579)
|
1,705
|
|